Product Creation Studio and Fred Hutchinson Cancer Research Center are working together to devise a better way to protect biopsy samples. Learn more in a recent article published by MD+DI.
Read MoreOur next DeviceConnect focuses on the emerging technologies and opportunities in digital health. Today’s innovators aren’t just promising small changes — they’re promising a better healthcare experience through more engaged patient involvement, better access to providers, and improved outcomes. Don’t miss this event on October 14!
Read MoreDrug Delivery Business News interviews Product Creation Studio CTO, Scott Thielman, in this article. “The vaccine delivery space was active before COVID-19, it’s no fluke that researchers were able to pivot quickly to produce candidate vaccines.”
Read MoreThe Product Creation Studio team is well-versed in designing minimally-invasive (MI) medical tools. Orthopedic Design & Technology writer, Mark Crawford, reached out to Product Creation Studio’s CTO, Scott Thielman to get thoughts on this trend in the orthopedic space.
Read MoreIn a recent MDDI article, our CTO Scott Thielman previews one of the stories he’ll share on MD&M’s Center Stage on August 12: the delivery of next generation nucleic acid vaccines—technology that may help to squelch the next pandemic.
Read MoreJoin us at MD&M West! From 3D printing and biomaterials to robotics and digital health, MD&M West is the largest medtech expo for suppliers and buyers to discover innovation, engineer new technology, and build life-changing medical devices.
Read MoreLearn how effective prototyping can significantly reduce time to market and overall development cost in this article for MD+DI by Product Creation Studio’s Michael Kahn.
Read More“Product Creation Studio is great about organizing teams of engineers and designers. The collaboration lets us specialize while staying connected to the big picture. This helps me understand the dimensionality of the project which is great to see.” - Tyler Barron, Embedded Systems Engineer at Product Creation Studio
Read MoreNext-generation vaccines are based on nucleic acid sequences that represent snippets of the genome from the pathogen we want immunity from, but there are design challenges in delivering these revolutionary vaccines.
Read MoreMassDevice editor, Sean Whooley, recently wrote an article about how PhysIQ’s partnership with J&J’s Janssen Pharmaceuticals. Our CTO, Scott Thielman, weighed in on the implications of this partnership to the future digital health landscape.
Read MoreOur CEO, Cameron Smith, shared his thoughts in this recent MPO article: “Medical Device Design for Smaller and Smarter MedTech.”
Read MoreCheck out highlights and video from from our most recent DeviceConnect event!
Read More